Reversal of hyperglycemia and diabetic nephropathy: Effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats

Journal of Diabetes and its Complications

Volumn 18, Issue 5, 2004, Pages 282-288

  Kowluru, Renu A ^a   Abbas, Saiyeda N ^a   Odenbach, Sarah ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Glycemic control; Nephropathy; Nitric oxides; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; GLUTATHIONE; GLYCOSYLATED HEMOGLOBIN; LIPID PEROXIDASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; HYPERGLYCEMIA; KIDNEY; KIDNEY CORTEX; MALE; METABOLIC REGULATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; URINE;

ANIMALS; BODY WEIGHT; DEOXYGUANOSINE; DIABETIC NEPHROPATHIES; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY CORTEX; MALE; NITRIC OXIDE; ORGAN SIZE; OXIDATIVE STRESS; PROTEINURIA; RATS; RATS, WISTAR; URINE;

EID: 4444335298     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2004.03.002     Document Type: Article

References (32)

1. Agardh C.-D., Stenram U., Torrfvit O., Agardh E. Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. Journal of Diabetes and Its Complications. 16:2002;395-400
2. Armstrong D., Abdella N., Salman A., Miller N., Rahman E.A., Bojancyzk M. Relationship of lipid peroxides to diabetic complications. Journal of Diabetes and Its Complications. 6:1992;116-122
3. Baumgartner-Parzer S.M., Wagner L., Pettermann M., Grillari J., Gessl A., Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes. 44:1995;1323-1327
4. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412
5. Behar-Cohen F.F., Heydolph S.F.V., Droy-Lefaix M.T., Courtois Y., Goureau O. Peroxynitrite cytotoxicity on bovine retinal pigmented epithelial cells in culture. Biochemical and Biophysical Research Communications. 226:1996;842-849
6. Bojestig M., Arnqvist H.J., Karlberg B.E., Ludvigsson J. Glycemic control and prognosis in type I diabetic patients with microalbuminuria. Diabetes Care. 19:1996;313-317
7. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes. 50:2001;2114-2145
8. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 329:1993;977-986
9. Du X., Stocklauser-Farber K., Rosen P. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radical Biology and Medicine. 27:1999;752-763
10. Goor Y., Peer G., Iaina A., Blum M., Wollman Y., Chernihovsky T., Silverberg D., Cabili S. Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats. Diabetologia. 39:1996;106-1040
11. Ha H., Kim K.H. Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Research and Clinical Practice. 45:1999;147-151
12. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Letters. 411:1997;157-160
13. Hinokio Y., Suzuki S., Hirai M., Suzuki C., Suzuki M., Toyota T. Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia. 45:2002;877-882
14. Hiragushi K., Sugimoto H., Shikata K., Yamashita T., Miyatake N., Shikata Y., Wada J., Kumagai I., Fukushima M., Makino H. Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes. Diabetes Research and Clinical Practice. 53:2001;149-159
15. Kakimoto M., Inoguchi T., Sonta T., Yu H.Y., Imamura M., Etoh T., Hashimoto T., Nawata H. Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes. 51:2002;1588-1595
16. Kern T.S., Engerman R.L. Arrest of glomerulopathy in diabetic dogs by improved glycemic control. Diabetologia. 33:1990;522-525
17. Kikkawa R., Koya D., Haneda M. Progression of diabetic nephropathy. American Journal of Kidney Diseases. 43:2003;S19-S21
18. Kowluru R.A. Effect of re-institution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 52:2003;818-823
19. Kowluru R.A., Koppolu P. Diabetes-induced activation of Caspase-3 in retina: effect of antioxidant therapy. Free Radical Research. 36:2002;993-999
20. Kowluru R.A., Koppolu P., Chakrabarti S., Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radical Research. 37:2003;1169-1180
21. Kowluru R.A., Tang J., Kern T.S. Abnormalities of retinal metabolism in diabetes and experimental galactosemia: VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes. 50:2001;1938-1942
22. Lepore G., Bruttomesso D., Nosari I., Tiengo A., Trevisan R. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients. Diabetes, Nutrition and Metabolism. 15:2002;232-239
23. Melhem M.F., Craven P.A., Liachenko J., DeRubertis F.R. Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. Journal of the American Society of Nephrology. 13:2002;108-116
24. Morioka T., Emoto M., Tabata T., Shoji T., Tahara H., Kishimoto H., Ishimura E., Nishizawa Y. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care. 24:2001;909-913
25. Nishikawa T., Sasahara T., Kiritoshi S., Sonoda K., Senokuchi T., Matsuo T., Kukidome D., Wake N., Matsumura T., Miyamura N., Sakakida M., Kishikawa H., Araki E. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care. 26:2003;1507-1512
26. Obrosova I.G., Fathallah L., Liu E., Nourooz-Zadeh J. Early oxidative stress in the diabetic kidney: effect of DL-[alpha]-lipoic acid. Free Radical Biology and Medicine. 34:2003;186-195
27. Pugliese G., Pricci F., Pesce C., Romeo G., Lenti E., Caltabiano V., Vetri M., Purrello F., Di Mario U. Early but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes. 46:1997;1198-1206
28. Reddi A.S., Bollineni J.S. Renal cortical expression of mRNAs for antioxidant enzymes in normal and diabetic rats. Biochemical and Biophysical Research Communications. 235:1997;598-601
29. Sugimoto K., Tsuruoka S., Fujimura A. Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. Clinical and Experimental Pharmacology and Physiology. 28:2001;826-830
30. Tannous M., Veluthakal R., Amin R., Kowluru A. IL-1 induced nitric oxide release from insulin-secreting beta cells: further evidence for the involvement of GTP-binding proteins. Diabetes and Metabolism. 28:2002;3S78-3S84
31. Thuraisingham R.C., Nott C.A., Dodd S.M., Yaqoob M.M. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney International. 57:2000;1968-1972
32. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Sustained effect of intensive treatment of Type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA, Journal of the American Medical Association. 290:2003;2159-2167